Alembic Pharma secures USFDA nod for generic heart failure medication

Alembic Pharmaceuticals has received final USFDA approval for Ivabradine tablets, aimed at reducing hospitalisations due to heart failure. Shares rose over 1.3% following the announcement, reflecting market optimism.